Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists
The Go-to Podcast for Biotech Scientists Who Want to Master Bioprocess CMC Development and Manufacturing of Biologics.
**TOP 10 LIFE SCIENCES PODCAST**
Do you want to simplify bioprocessing so that you can scale with confidence and reduce time to market?
Are you sick of feeling overwhelmed by the complexity and guesswork of biologics drug development?
Do you wish you had more time to enjoy the beauty of science, without worrying about failing your cell culture process development and commercialization?
There’s a way to simplify and streamline so you can remove complexity, skip trials and errors, deliver without delay your groundbreaking therapy to clinics and market, and still enjoy every single step.
Hey, I’m David Brühlmann, biotech entrepreneur and consultant, international technology transfer expert, and innovation coach. I’ve been there. And guess what, science may give you headaches, but biologics drug development should not.
Want to learn how I and many industry experts did it?
- In this podcast, you will learn:
- How to develop bioprocesses with peace of mind
- How to master biologics drug development
- How to deliver your life-transforming therapy to clinics and market fast and efficiently
- How to actually enjoy doing all this
I can’t wait to help you do biotech the smart way.
Grab a cup of coffee and your favorite notebook and pen. Now is the time to take your bioprocessing game to the next level.
Ready? Binge-listen mode: Go!
Next Steps:
Visit the Website: www.smartbiotechscientist.com
Email us: hello@bruehlmann-consulting.com
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists
82: Regenerating Muscles: The Future of Autologous Cell-based Therapy with Deana Mohr - Part 2
Dive into the cutting-edge world of autologous cell-based therapy with Deana Mohr, CEO and co-founder of MUVON Therapeutics, spin-off from the University of Zurich. In this eye-opening episode, discover how MUVON Therapeutics’ innovative approach to muscle regeneration is revolutionizing treatments for stress urinary incontinence and beyond.
Learn how her team is tackling the challenges of bringing personalized medicine to market at scale, from navigating complex regulations to automating production processes.
Listeners will gain invaluable insights on:
- Strategies for engaging with regulatory bodies to advance novel therapies
- The crucial role of automation in making cell therapies accessible and affordable
- Building successful partnerships to accelerate biotech innovation
Whether you're a scientist, investor, or healthcare professional, this episode offers a fascinating glimpse into the future of regenerative medicine. Tune in to explore how Deana's vision of "copy-paste" therapy production could transform millions of lives and reshape the biotech landscape!
Connect with Deana Mohr:
LinkedIn: https://www.linkedin.com/in/deana-mohr-haralampieva-95a9a5a4
MUVON Therapeutics: https://www.muvon-therapeutics.com
Next Steps:
Wondering how to develop cell and gene therapies with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment
Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? DM us at hello@bruehlmann-consulting.com